General Information of the Compound
| Compound ID |
CP0502694
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(2-(allyl(1-(2-(1-(5-(N-tert-butylsulfamoyl)-2-chloro-4-fluorobenzoyl)-4-(3-fluorophenyl)piperidin-4-yl)ethyl)piperidin-4-yl)amino)-2-oxoethyl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C41H50ClF2N5O5S
|
||||||||||||||||||
| Molecular Weight |
798.397
|
||||||||||||||||||
| Canonical SMILES |
CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(CC3)N(CC=C)C(=O)Cc3ccc(cc3)C(N)=O)(CC2)c2cccc(F)c2)c(Cl)cc1F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C41H50ClF2N5O5S/c1-5-18-49(37(50)24-28-9-11-29(12-10-28)38(45)51)32-13-19-47(20-14-32)21-15-41(30-7-6-8-31(43)25-30)16-22-48(23-17-41)39(52)33-26-36(35(44)27-34(33)42)55(53,54)46-40(2,3)4/h5-12,25-27,32,46H,1,13-24H2,2-4H3,(H2,45,51)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SYLAELUHIQTVAM-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound